Skip to main content
. 2015 Jul 24;30(Suppl 4):iv6–iv16. doi: 10.1093/ndt/gfv131

Table 2.

Laboratory assessment of kidney function, CKD definition used and details on the reporting of CKD prevalence per study

Author (Ref.) Creatinine assay IDMS Albuminuria CKD definition eGFR equation Ethnicity CI Age and sex standardized Stratified prevalence
Aumann et al. [10] Jaffe Other n/a 2 CKD-EPI + other Yes n/a No Yes: other
Bongard et al. [11] Jaffe No n/a 2 MDRD (old) No Yes Yes to national pop. No
Browne et al. [12] Modified Jaffe Yes Other 1 + 2 CKD-EPI + new MDRD No Yes Yes to national pop. Yes: age, sex and other
Capuano et al. [13] Modified Jaffe No n/a 2 CG No No Yes to national pop. Yes: age, sex and other
Christensson et al. [14] Unclear Other n/a Other CKD-EPI, MDRD (old) + CG Yes No No Yes: age and sex
Chudek et al. [15] Jaffe Unclear If dipstick − → immunoassay 1 + 2 + 3 CKD-EPI No No No Yes: age, sex and other
Cirillo et al. [16] Modified Jaffe No Immunoassay 2 MDRD (old) Yes Yes for N
Not for %
Yes to national pop. Yes: age and sex
Codreanu et al. [17] Unclear No Other 2 + 3 MDRD (old) No No No Yes: age, sex and other
De Nicola et al. [18] Enzymatic Yes Immunoassay 1 + 2 + 3 CKD-EPI No Yes No No
Delanaye et al. [19] Compensated Jaffe Yes n/a 2 CKD-EPI + new MDRD No No No Yes: sex
Donfrancesco et al. [20] Enzymatic Yes n/a 2 CKD-EPI No No No Yes: sex
Formiga et al. [21] Compensated Jaffe No n/a 2 MDRD (old) No No No No
Fraser et al. [22] Enzymatic Yes Not specified 1 + 2 + 3 + other CKD-EPI + new MDRD Yes No Unclear Yes: other
Gambaro et al. [23] Modified Jaffe Other If dipstick + → immunoassay 1 + 2 + 3 CKD-EPI Yes Yes Yes to US pop. Yes: age, sex and other
Gianelli et al. [24] Modified Jaffe No n/a 2 MDRD (old) and CG No No No No
Goek et al. [25] Compensated Jaffe Unclear n/a 2 CKD-EPI No n/a No No
Gu et al. [26] Modified Jaffe Unclear Not specified 2 CKD-EPI + MDRD (old) No No No No
Guessous et al. [27] Compensated Jaffe Unclear Unclear 1 CKD-EPI Yes n/a No No
Hallan et al. [28] Jaffe Other Immunoassay 1 + 2 + 3 New MDRD Yes Yes Yes to national + US pop. Yes: age, sex and other
Hernandez et al. [29] Not specified Unclear Not specified 1 + other CKD-EPI Yes n/a No Yes: other
Juutilainen et al. [30] Enzymatic Yes n/a 2 + other CKD-EPI + new MDRD No no No Yes: age and sex
Lieb et al. [31] Enzymatic No Immunoassay 3 + other MDRD (old) No n/a No No
Meuwese et al. [32] Jaffe No n/a 2 CKD-EPI + MDRD (old) No n/a No No
Nitsch et al. [33] Modified Jaffe Other n/a 2 MDRD (old) Yes n/a No Yes: other
Nitsch et al. [34] Jaffe Other n/a 2 MDRD (old) and CG Yes Yes No Yes: age and sex
Otero et al. [35] Unclear Unclear Unclear 1 + 2 MDRD (old) Yes Yes Yes to national pop. Yes: age, sex and other
Pani et al. [36] Not specified Other Not specified 1 + 2 + 3 CKD-EPI + new MDRD No Yes No Yes: age and sex
Pattaro et al. [37] Enzymatic Yes n/a 2 CKD-EPI, new MDRD + other No Yes No Yes: age
Ponte et al. [38] Compensated Jaffe Yes Immunoassay 1 + 2 + 3 CKD-EPI + new MDRD Yes Yes No Yes: age and sex
Redon et al. [39] Jaffe Yes Immunoassay 2 CG No n/a No No
Robles et al. [40] Modified Jaffe + enzymatic No Dipstick 2 + other CKD-EPI + new MDRD Yes Yes Yes to EU pop. Yes: age and sex
Roderick et al. [41] Modified Jaffe Yes Immunoassay 2 + other MDRD (old) No Yes No Yes: age and sex
Rothenbacher et al. [42] Modified Jaffe No If dipstick + → immunoassay 1 + 2 + 3 CKD-EPI + new MDRD No No No Yes: age and sex
Rutkowski et al. [43] Modified Jaffe Unclear n/a 1 + 2 + 3 MDRD (old) No No No No
Sahin et al. [44] Enzymatic Yes Not specified 2 New MDRD No No No Yes: age, sex and other
Schaeffner et al. [45] Unclear Unclear Immunoassay 2 CKD-EPI + other Yes n/a No No
Scheven et al. [46] Modified Jaffe Unclear If dipstick + → immunoassay 1 + 2 + 3 CKD-EPI No n/a No* No
Stasevic et al. [47] Jaffe Yes Unclear 2 + 3 + other MDRD (old) No No No No
Stengel et al. [48] Jaffe Yesa Immunoassay 1 + 2 CKD-EPI + new MDRD No No No Yes: age and sex
Suleymanlar et al. [49] Not specified No Not specified 1 + 2 + 3 MDRD (old) Yes No Yes to national pop. Yes: age and sex
Tavira et al. [50] Modified Jaffe No n/a 2 MDRD (old) Yes n/a No No
Van Pottelbergh et al. [51] Modified Jaffe No Dipstick 2 MDRD (old) and CG No No No Yes: age and sex
Viktorsdottir et al. [52] Modified Jaffe No n/a 1 + 2 + 3 MDRD (old) and CG Yes No Yes to global pop. Yes: age and sex
Vinhas et al. [53] Jaffe Unclear Immunoassay 2 MDRD (old) No Yes Yes to national pop. Yes: age, sex and other
Wasen et al. [54] Unclear Yes n/a 2 + other New MDRD and CG No No No Yes per sex
Wetmore et al. [55] Jaffe Other Dipstick 2 New MDRD and CG Yes No No No
Zambon et al. [56] Modified Jaffe No Immunoassay 2 + other CKD-EPI and MDRD (old) Yes n/a Yes to national pop. No
Zhang et al. [57] Modified Jaffe Other n/a 2 + other MDRD (old) No No No Yes: age, sex and other

Albuminuria = method of albuminuria measurement; CKD definition 1 = eGFR below 60 mL/min/1.73 m2 and or the presence of albuminuria >30 mg/g (i.e. CKD Stages 1–5); 2 = eGFR below 60 mL/min/1.73 m2 (i.e. CKD Stages 3–5); 3 = albuminuria >30 mg/g. Ethnicity = ‘yes’ if collection is reported; ‘no’ if not reported or not collected. CI, confidence interval given for prevalence estimate; CG, Cockcroft and Gault equation; n/a, not applicable.

aIn order to standardize creatinine values, 1720 frozen serum samples were remeasured in a single laboratory with an IDMS-traceable enzymatic assay. Hereafter, equations relating the Jaffe and IDMS-traceable creatinine were developed to standardize all baseline values as follows: ScrIDMS = 0.86 × ScrJaffe + 4.40. *Population corrected for sampling design (i.e. oversampling of albuminuria).